Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre.

Chetcuti Zammit, S; Sanders, D S; Sidhu, R

Chetcuti Zammit, S; Sanders, D S; Sidhu, R.

Affiliation

Chetcuti Zammit S; a Department of Gastroenterology , Royal Hallamshire Hospital , Sheffield, UK.
Sanders DS; a Department of Gastroenterology , Royal Hallamshire Hospital , Sheffield, UK.
Sidhu R; a Department of Gastroenterology , Royal Hallamshire Hospital , Sheffield, UK.

Scand J Gastroenterol ; 52(9): 962-968, 2017 Sep.

Article in En | MEDLINE | ID: mdl-28506132

Subject(s)

Gastrointestinal Hemorrhage/therapy; Intestine, Small/drug effects; Peptides, Cyclic/administration & dosage; Somatostatin/analogs & derivatives; Adult; Aged; Aged, 80 and over; Blood Transfusion; Capsule Endoscopy; Female; Humans; Intestine, Small/pathology; Male; Middle Aged; Quality of Life; Retrospective Studies; Somatostatin/administration & dosage; United Kingdom

Key words

Lanreotide; argon plasma coagulation; bleeding episodes; double balloon enteroscopies; haemoglobin; packed red cells; small bowel angioectasias; somatostatin analogues; transfusion

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Somatostatin / Gastrointestinal Hemorrhage / Intestine, Small Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Scand J Gastroenterol Year: 2017 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google